A PHASE 2 DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF GS 4997 IN SUBJECTS WITH DIABETIC KIDNEY DISEASE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Hura,Claudia E.

Funded by

GILEAD SCIENCE

Research Start Date

01/01/2017

Status

Inactive

Clinical Care

Drug Discovery

Diabetes and Obesity

Bioscience Research Panel